Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-24-005271
Filing Date
2024-11-14
Accepted
2024-11-14 16:39:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 alyeska-blue093024a1.htm SC 13G/A 102631
  Complete submission text file 0001172661-24-005271.txt   104327
Mailing Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145
Business Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145 339-499-9300
bluebird bio, Inc. (Subject) CIK: 0001293971 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87526 | Film No.: 241463514
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 77 WEST WACKER DRIVE 7TH FLOOR CHICAGO IL 60601
Business Address 77 WEST WACKER DRIVE 7TH FLOOR CHICAGO IL 60601 312-899-7902
Alyeska Investment Group, L.P. (Filed by) CIK: 0001453072 (see all company filings)

EIN.: 261919051 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A